GARY RODRIGUEZ

Allopathic & Osteopathic Physicians|Family Medicine BERWYN, IL NPI 1447646641

General Payments — all program years on this page

$1,098.83

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $976.22 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $976.2221

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $248.526
Novo Nordisk AS $244.627
Acerta Pharma LLC $239.602
Madrigal Pharmaceuticals $118.161
QOL Medical, LLC $65.813
PFIZER INC. $36.851
ABBVIE INC. $22.661

By program year

Program yearAmountRecords
2023 $122.611
2024 $976.2221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096946078 Novo Nordisk Inc $20.39 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096962326 Novo Nordisk Inc $18.27 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097252864 Novo Nordisk Inc $120.89 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097478166 Novo Nordisk Inc $23.21 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097589833 Novo Nordisk Inc $19.88 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097595756 Novo Nordisk Inc $22.36 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097823612 Novo Nordisk Inc $19.62 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104507834 AstraZeneca Pharmaceuticals LP $120.37 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105858856 AstraZeneca Pharmaceuticals LP $119.23 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105964278 ABBVIE INC. $22.66 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131181977 PFIZER INC. $36.85 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134977248 Lilly USA, LLC $120.89 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134982628 Lilly USA, LLC $20.49 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134983374 Lilly USA, LLC $24.83 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134994938 Lilly USA, LLC $25.65 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135000558 Lilly USA, LLC $25.84 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135000560 Lilly USA, LLC $30.82 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144180507 Madrigal Pharmaceuticals $118.16 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147711306 QOL Medical, LLC $19.80 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147711308 QOL Medical, LLC $20.19 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147711310 QOL Medical, LLC $25.82 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.